speb/financial-data huggingface dataset:
Stock screener scorecard for KRONOX.NS (annual, report date 2026-03-31)
Altman Z-score: 32.43247062458897 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 32.85211806086558%
Earnings yield: 0.06572379846319798%
Return on net tangible assets: 23.00498592058694%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 27.504587939055096%
Free cash flow margin: 20.33738391622209%
Revenue growth: -8.418883982285037%
Rule of 40 score: 11.918499933937055
Market cap: 5728486400 (Mid Cap ($2B-$10B))
P/E ratio: 0.13721631072267254
Debt to equity: 0.0138
Free cash flow (dilution adjusted): 2181591.776176346
Operating income: 3414900.3815175924
Net income: 2931326.8334039846
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for KRONOX.NS (quarterly, report date 2026-03-31)
Altman Z-score: 31.23903665581471 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 9.033389407146863%
Earnings yield: 0.01807215789663654%
Return on net tangible assets: 7.458386077311909%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.562972130937647%
Revenue growth: -1.6561465985197414%
Rule of 40 score: -1.6561465985197414
Market cap: 5728486400 (Mid Cap ($2B-$10B))
P/E ratio: 0.13721631072267254
Debt to equity: 0.0138
Operating income: 938999.5760915643
Net income: 848039.4234845274
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PSFE (quarterly, report date 2026-03-31)
Altman Z-score: 0.20839836992802468 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.6755648907544187%
Earnings yield: 0.5311070940649539%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.33619078951452214%
Free cash flow margin: 4.0113118134815675%
Revenue growth: -1.6613487386154806%
Rule of 40 score: 2.349963074866087
Market cap: 410826976 (Small Cap ($300M-$2B))
Debt to equity: 4.111000000000001
Free cash flow (dilution adjusted): 23367105.263157893
Operating income: 14252631.578947369
Net income: -47963157.89473684
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for REZI (quarterly, report date 2026-03-31)
Altman Z-score: 1.1838673841543257 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 6.324868231911836%
Earnings yield: 1.5020033119373295%
Return on net tangible assets: -4.263877715205148%
Capitalized R&D asset: 94010000
ROCI (R&D adjusted): 1.9743939324560325%
Rosenberg metric: -0.19148936170212766
Free cash flow margin: -10.198744769874477%
Revenue growth: 0.8970976253298154%
Rule of 40 score: -9.301647144544662
Market cap: 5230262784 (Mid Cap ($2B-$10B))
P/E ratio: 33.58275805657895
Debt to equity: 1.2033
Free cash flow (dilution adjusted): -195000000
Operating income: 132000000
Net income: 38000000
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SIFY (annual, report date 2026-03-31)
Altman Z-score: 1.2532916839260944 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.415552337960991%
Earnings yield: 0.07018559546977209%
Return on net tangible assets: -37.93912284529783%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.292092598447325%
Free cash flow margin: -12.857365688437284%
Revenue growth: 1.9963535542170647%
Rule of 40 score: -10.86101213422022
Market cap: 1150371328 (Small Cap ($300M-$2B))
Debt to equity: 2.605556435852743
Free cash flow (dilution adjusted): -61148791.86095803
Operating income: 31930902.924968205
Net income: -14476473.081814328
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for SYL.AX (annual, report date 2025-06-30)
Altman Z-score: 3.2857429315301383 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 20.153195372432563%
Earnings yield: 4.756119141838312%
Return on net tangible assets: 10.596517506085009%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.57786283999123%
Free cash flow margin: 4.085152341973624%
Revenue growth: 16.048034070309583%
Rule of 40 score: 20.13318641228321
Market cap: 676777472 (Small Cap ($300M-$2B))
P/E ratio: 4.872251931075461
Debt to equity: 0.9236
Free cash flow (dilution adjusted): 23485620.91503268
Operating income: 34066013.07189542
Net income: 23456209.150326796
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for TTKPRESTIG.NS (quarterly, report date 2026-03-31)
Altman Z-score: 8.847455360815292 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.1750639284001916%
Earnings yield: 0.005688304199753231%
Return on net tangible assets: 3.2232679150740378%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.011946945582725%
Revenue growth: -13.438903892541592%
Rule of 40 score: -13.438903892541592
Market cap: 88117321728 (Large Cap ($10B-$200B))
P/E ratio: 0.38626013155729955
Debt to equity: 0.08800000000000001
Operating income: 4615303.094531581
Net income: 3902077.1513353116
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for TTKPRESTIG.NS (annual, report date 2026-03-31)
Altman Z-score: 9.847907477543611 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 9.823497682595491%
Earnings yield: 0.025690758967840715%
Return on net tangible assets: 8.2313515133995%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.086793219900487%
Free cash flow margin: 4.027118644067797%
Revenue growth: -0.6874645722661512%
Rule of 40 score: 3.339654071801646
Market cap: 88117321728 (Large Cap ($10B-$200B))
P/E ratio: 0.38626013155729955
Debt to equity: 0.08800000000000001
Free cash flow (dilution adjusted): 12590080.542602798
Operating income: 20844637.55828741
Net income: 17018863.925392114
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for TXG.TO (quarterly, report date 2026-03-31)
Altman Z-score: 7.352338520861557 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 11.915430992341534%
Earnings yield: 4.150786772719291%
Return on net tangible assets: 8.551351780539123%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.943579766536965%
Free cash flow margin: 34.86000370851103%
Revenue growth: 14.236038635242698%
Rule of 40 score: 49.09604234375373
Market cap: 5098580992 (Mid Cap ($2B-$10B))
P/E ratio: 5.2119396632864365
Debt to equity: 0.0401
Free cash flow (dilution adjusted): 135251798.5611511
Operating income: 210431654.676259
Net income: 149280575.53956836
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 1565.HK (annual, report date 2025-08-31)
Altman Z-score: 0.2791654533583325 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.37243294800313%
Earnings yield: 0.9907648100405265%
Return on net tangible assets: 27.183412729264067%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.967370837170305%
Free cash flow margin: 35.01851457128594%
Revenue growth: 12.674537157448484%
Rule of 40 score: 47.693051728734424
Market cap: 531687776.82926834 (Small Cap ($300M-$2B))
P/E ratio: 9.215331683812886
Debt to equity: 2.505918130396643
Free cash flow (dilution adjusted): 53078321.678321674
Operating income: 25523496.5034965
Net income: 8069370.629370629
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ALHC (annual, report date 2025-12-31)
Altman Z-score: 5.633066364394621 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 3.1657943135020523%
Earnings yield: 0.4074560389404234%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.8986874164898215%
Free cash flow margin: 1.2931788764913381%
Revenue growth: 46.05621992623802%
Rule of 40 score: 47.34939880272936
Market cap: 4082993004.25 (Mid Cap ($2B-$10B))
Debt to equity: 1.838735587944912
Free cash flow (dilution adjusted): 51064000
Operating income: 14752000
Net income: -724000
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for BHP (annual, report date 2025-06-30)
Altman Z-score: 3.622390957265963 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 22.80747895944912%
Earnings yield: 5.34546937848358%
Return on net tangible assets: 16.443210545323222%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.480724844607142%
Free cash flow margin: 18.130388982092%
Revenue growth: -9.704152601426506%
Rule of 40 score: 8.426236380665495
Market cap: 183298092044.24158 (Large Cap ($10B-$200B))
P/E ratio: 16.44961788066424
Debt to equity: 0.4691102684897927
Free cash flow (dilution adjusted): 6074509803.921569
Operating income: 12469281045.751635
Net income: 7283006535.947712
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for COP (annual, report date 2025-12-31)
Altman Z-score: 2.789090407339014 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 11.717063192801579%
Earnings yield: 6.9380202338244406%
Return on net tangible assets: 11.03478220416518%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.314003291896661%
Free cash flow margin: 12.28793431053203%
Revenue growth: 7.670106859073888%
Rule of 40 score: 19.95804116960592
Market cap: 112326707445.40001 (Large Cap ($10B-$200B))
P/E ratio: 14.0619313276665
Debt to equity: 0.36354614108269884
Free cash flow (dilution adjusted): 7243000000
Operating income: 11342000000
Net income: 7988000000
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EW (annual, report date 2025-12-31)
Altman Z-score: 11.490776832199508 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 23.92175209801456%
Earnings yield: 3.6678077925522903%
Return on net tangible assets: 13.034888721642835%
Capitalized R&D asset: 2102467000
ROCI (R&D adjusted): 12.038495443325441%
Rosenberg metric: 0.39069325735992405
Free cash flow margin: 19.39646647768475%
Revenue growth: 11.54701718907988%
Rule of 40 score: 30.943483666764628
Market cap: 49086950000 (Large Cap ($10B-$200B))
P/E ratio: 45.726082906380995
Debt to equity: 0.06823634112366507
Free cash flow (dilution adjusted): 1176900000
Operating income: 1636200000
Net income: 1073500000
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for FLL (annual, report date 2025-12-31)
Altman Z-score: 0.28398523196250913 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.7773486507096997%
Earnings yield: 0.5941800386576679%
Capitalized R&D asset: 574050
ROCI (R&D adjusted): 0.6140896268635522%
Rosenberg metric: 16.877717391304348
Free cash flow margin: -1.4607640818054344%
Revenue growth: 3.530378511632685%
Rule of 40 score: 2.0696144298272507
Market cap: 94652127.63 (Micro Cap ($50M-$300M))
Debt to equity: 209.45784081954295
Free cash flow (dilution adjusted): -4417000
Operating income: 3476000
Net income: -40197000
Long score: 0 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for JMT.LS (annual, report date 2025-12-31)
Altman Z-score: 2.878376055463112 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 18.22360616844602%
Earnings yield: 10.047302095262868%
Return on net tangible assets: 30.71025020177563%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.268977512734496%
Free cash flow margin: 3.8009502375593898%
Revenue growth: 21.469814796585602%
Rule of 40 score: 25.270765034144993
Market cap: 12304742027.599998 (Large Cap ($10B-$200B))
P/E ratio: 18.700215847416413
Debt to equity: 1.5789175403797104
Free cash flow (dilution adjusted): 1609411764.7058823
Operating income: 1445882352.9411764
Net income: 774117647.0588236
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for PSFE (annual, report date 2025-12-31)
Altman Z-score: -0.13862356142707827 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 30.234642776005288%
Earnings yield: 6.165495759534235%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.611965563353877%
Free cash flow margin: 4.459535391104205%
Revenue growth: 7.889524697602894%
Rule of 40 score: 12.349060088707098
Market cap: 306830401.60899997 (Small Cap ($300M-$2B))
Debt to equity: 4.057874593343584
Free cash flow (dilution adjusted): 102532432.43243244
Operating income: 165455405.4054054
Net income: -246631081.0810811
Long score: 5 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for QDEL (annual, report date 2025-12-31)
Altman Z-score: 0.6665760344954318 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.7468671679198%
Earnings yield: 1.4312707544706629%
Capitalized R&D asset: 413579000
ROCI (R&D adjusted): 0.46708259381251643%
Rosenberg metric: -0.056241426611796985
Free cash flow margin: -4.721265841330306%
Revenue growth: -1.8937080024434942%
Rule of 40 score: -6.6149738437738
Market cap: 1947534645.84 (Small Cap ($300M-$2B))
Debt to equity: 1.4756053111168967
Free cash flow (dilution adjusted): -128900000
Operating income: 54800000
Net income: -1131800000
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for REZI (annual, report date 2025-12-31)
Altman Z-score: 2.0007302678748626 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 31.26829268292683%
Earnings yield: 7.293819113271425%
Capitalized R&D asset: 277340000
ROCI (R&D adjusted): 9.76228336788712%
Rosenberg metric: 2.6576576576576576
Free cash flow margin: -17.532119914346893%
Revenue growth: 10.516195829019376%
Rule of 40 score: -7.0159240853275175
Market cap: 5318090251.2 (Mid Cap ($2B-$10B))
Debt to equity: 1.1052451148440179
Free cash flow (dilution adjusted): -1310000000
Operating income: 641000000
Net income: -527000000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for TXG.TO (annual, report date 2025-12-31)
Altman Z-score: 7.599946008218144 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 22.22734899328859%
Earnings yield: 7.629440778840585%
Return on net tangible assets: 9.045578175224597%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.23445853062471%
Free cash flow margin: 7.78952205882353%
Revenue growth: 22.16759856959171%
Rule of 40 score: 29.95712062841524
Market cap: 6089919984.12 (Mid Cap ($2B-$10B))
P/E ratio: 15.096479881308872
Debt to equity: 0.054891617901590695
Free cash flow (dilution adjusted): 74233576.64233576
Operating income: 386788321.16788316
Net income: 294452554.74452555
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ZIM (annual, report date 2025-12-31)
Altman Z-score: 1.9046819359789222 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 13.118690386171581%
Earnings yield: 4.535912121681672%
Return on net tangible assets: 44.254122459414546%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.143790849673204%
Free cash flow margin: 30.152660699284496%
Revenue growth: -5.965872327506747%
Rule of 40 score: 24.186788371777748
Market cap: 7872007128.0552 (Mid Cap ($2B-$10B))
P/E ratio: 16.34892446117383
Debt to equity: 1.4225457074721781
Free cash flow (dilution adjusted): 654654088.0503144
Operating income: 310974842.7672956
Net income: 151415094.33962265
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 0320.HK (annual, report date 2026-03-31)
Altman Z-score: 2.356504794435177 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.3455850477353675%
Earnings yield: 2.4350286703368273%
Return on net tangible assets: 8.809926745047187%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.820957396915554%
Free cash flow margin: 3.514945167595969%
Revenue growth: 1.9230636857655543%
Rule of 40 score: 5.438008853361524
Market cap: 400206496 (Small Cap ($300M-$2B))
P/E ratio: 2.933673469387755
Debt to equity: 0.1607
Free cash flow (dilution adjusted): 18403571.42857143
Operating income: 9466454.081632653
Net income: 2645790.8163265307
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 0470.HK (quarterly, report date 2026-03-31)
Altman Z-score: 1.71146966302786 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 2.668479970870079%
Earnings yield: 0.17529653292682995%
Return on net tangible assets: 2.159173718541817%
Capitalized R&D asset: 114263314.15410116
ROCI (R&D adjusted): 2.252840906206433%
Rosenberg metric: -0.3769820890364809
Free cash flow margin: 32.30759679741693%
Revenue growth: -6.638498838868019%
Rule of 40 score: 25.66909795854891
Market cap: 48251060224 (Large Cap ($10B-$200B))
P/E ratio: 4.40104613273881
Debt to equity: 0.20129999999999998
Free cash flow (dilution adjusted): 172555809.08972502
Operating income: 67106383.965267725
Net income: 58667853.96237337
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 1358.HK (annual, report date 2025-12-31)
Altman Z-score: 3.6712960583682306 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 3.3134928107868715%
Earnings yield: 2.1526401680681007%
Return on net tangible assets: 7.925819100124791%
Capitalized R&D asset: 12873357.204785852
ROCI (R&D adjusted): 2.0890737575183667%
Rosenberg metric: 0.12406003108405717
Free cash flow margin: 13.260271643766586%
Revenue growth: 11.691340966099945%
Rule of 40 score: 24.95161260986653
Market cap: 1516899200 (Small Cap ($300M-$2B))
P/E ratio: 2.33198677928755
Debt to equity: 0.0045000000000000005
Free cash flow (dilution adjusted): 15599857.142857146
Operating income: 14578857.142857144
Net income: 19321857.14285714
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for 1702.HK (annual, report date 2025-12-31)
Altman Z-score: 4.55449263540987 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 7.198833320322917%
Earnings yield: 5.843403279966856%
Return on net tangible assets: -2.4883511471842343%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.1567622047244095%
Free cash flow margin: -0.3403505195033475%
Revenue growth: -3.475915141848588%
Rule of 40 score: -3.8162656613519355
Market cap: 894159424 (Small Cap ($300M-$2B))
P/E ratio: 0.909630215542812
Debt to equity: 0.0146
Free cash flow (dilution adjusted): -1159000
Operating income: 20288142.85714286
Net income: 20153857.14285714
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3718.HK (annual, report date 2025-12-31)
Altman Z-score: 1.8050176783871277 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 13.51859404744694%
Earnings yield: 2.4866339939196758%
Return on net tangible assets: 22.86556242385284%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.857604234183384%
Free cash flow margin: 9.758544929672333%
Revenue growth: 4.140793040200466%
Rule of 40 score: 13.899337969872798
Market cap: 1493798912 (Small Cap ($300M-$2B))
P/E ratio: 0.6977598237238339
Debt to equity: 0.6723
Free cash flow (dilution adjusted): 78939717.22365038
Operating income: 87379691.5167095
Net income: 36245372.75064267
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for 4685.T (annual, report date 2026-03-31)
Altman Z-score: 5.974488064847961 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 36.79485461610612%
Earnings yield: 0.12408740003898712%
Return on net tangible assets: 20.89951976357591%
Capitalized R&D asset: 1687594.9370924225
ROCI (R&D adjusted): 22.469478063982127%
Rosenberg metric: 0.91927504427505
Free cash flow margin: 8.11954937657591%
Revenue growth: -5.3738427879040085%
Rule of 40 score: 2.7457065886719008
Market cap: 36350644224 (Large Cap ($10B-$200B))
P/E ratio: 0.059326919693449394
Debt to equity: 0.0003
Free cash flow (dilution adjusted): 21959459.459459458
Operating income: 34359359.35935936
Net income: 25863363.363363363
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 5334.T (annual, report date 2026-03-31)
Altman Z-score: 4.471242934161244 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 17.380497674626056%
Earnings yield: 0.04230127827740137%
Return on net tangible assets: 15.328962803131182%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.541583402334231%
Revenue growth: -16.406527775931373%
Rule of 40 score: -16.406527775931373
Market cap: 1840354164736 (Mega Cap (>= $200B))
P/E ratio: 0.09697572916086986
Debt to equity: 0.3144
Operating income: 804523273.2732732
Net income: 580461711.7117116
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6955.HK (annual, report date 2025-12-31)
Altman Z-score: 1.697202856709831 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.2090909783926183%
Earnings yield: 0.21300105071417985%
Return on net tangible assets: 1.703516124789703%
Capitalized R&D asset: 45498392.761772655
ROCI (R&D adjusted): 0.43519783127897527%
Rosenberg metric: 0.2940056540321822
Free cash flow margin: -28.353945225796423%
Revenue growth: 12.686107502991614%
Rule of 40 score: -15.667837722804808
Market cap: 3068104960 (Mid Cap ($2B-$10B))
P/E ratio: 109.25449871465295
Debt to equity: 0.2859
Free cash flow (dilution adjusted): -31789714.285714287
Operating income: 5795714.285714285
Net income: 1020571.4285714285
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for A3M.MC (annual, report date 2025-12-31)
Altman Z-score: 2.0642350907972764 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 15.842147701939952%
Earnings yield: 7.775310122999898%
Return on net tangible assets: 15.28503490462844%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.545487122729283%
Free cash flow margin: 7.336432651371476%
Revenue growth: 9.842942916300363%
Rule of 40 score: 17.17937556767184
Market cap: 1143906432 (Small Cap ($300M-$2B))
P/E ratio: 22.023529411764706
Debt to equity: 0.2457
Free cash flow (dilution adjusted): 77140000
Operating income: 82517647.05882353
Net income: 73067058.8235294
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for CNR.TO (quarterly, report date 2026-03-31)
Altman Z-score: 2.315540036365819 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 3.2057119205298017%
Earnings yield: 0.836182827837271%
Return on net tangible assets: 6.082434882167733%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.821339453217493%
Free cash flow margin: 18.86275405343686%
Revenue growth: -3.315573347773384%
Rule of 40 score: 15.547180705663475
Market cap: 110642257920 (Large Cap ($10B-$200B))
P/E ratio: 13.15096831392396
Debt to equity: 1.0327
Free cash flow (dilution adjusted): 594244604.3165468
Operating income: 1114388489.2086332
Net income: 824460431.6546763
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for COGN3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 0.4961162644803645 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.725292259716792%
Earnings yield: 0.8227712395206063%
Return on net tangible assets: -24.66726363254994%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.992775362935112%
Free cash flow margin: 12.844434255552326%
Revenue growth: 1.5821428164608784%
Rule of 40 score: 14.426577072013204
Market cap: 4362679808 (Mid Cap ($2B-$10B))
P/E ratio: 1.7557593379557144
Debt to equity: 0.4892
Free cash flow (dilution adjusted): 52406463.878327
Operating income: 80630608.36501901
Net income: 26891064.638783272
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CYIENTDLM.NS (annual, report date 2026-03-31)
Altman Z-score: 5.00398368570188 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.673265176001593%
Earnings yield: 0.016946977861339127%
Return on net tangible assets: 8.998964118790072%
Capitalized R&D asset: 103163.29910033132
ROCI (R&D adjusted): 7.490745072674156%
Rosenberg metric: 95.87640723038946
Free cash flow margin: 0.9843161036397579%
Revenue growth: -24.746502517734513%
Rule of 40 score: -23.762186414094757
Market cap: 34364784640 (Large Cap ($10B-$200B))
P/E ratio: 0.31194017163926563
Debt to equity: 0.1702
Free cash flow (dilution adjusted): 1315917.761763459
Operating income: 9139889.783806698
Net income: 7766214.497668504
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for EIMCOELECO.NS (annual, report date 2026-03-31)
Altman Z-score: 10.963182865860501 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 12.56221055067505%
Earnings yield: 0.03557926997150362%
Return on net tangible assets: -2.583139512715905%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.202159892232109%
Free cash flow margin: -16.778332493839102%
Revenue growth: -15.239382832012707%
Rule of 40 score: -32.01771532585181
Market cap: 8811207680 (Mid Cap ($2B-$10B))
P/E ratio: 0.22420892509672985
Debt to equity: 0.009300000000000001
Free cash flow (dilution adjusted): -4073781.263247139
Operating income: 3635862.653666808
Net income: 4102723.6116998727
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for FMV.DE (quarterly, report date 2026-03-31)
Altman Z-score: 3.2294567179345477 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 5.758457058159494%
Earnings yield: 2.489564330374234%
Return on net tangible assets: 6.599073133228292%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.447827799347954%
Free cash flow margin: 38.5078741958423%
Revenue growth: 1.3474050015348042%
Rule of 40 score: 39.8552791973771
Market cap: 7223848960 (Mid Cap ($2B-$10B))
P/E ratio: 39.96463306808134
Debt to equity: 0.0947
Free cash flow (dilution adjusted): 133236690.64748204
Operating income: 169768345.32374102
Net income: 106105035.97122303
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for GRAUWEIL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.361106168815496 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 6.24882430398796%
Earnings yield: 0.01929664111004909%
Return on net tangible assets: 5.159981764218792%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.715181731886693%
Revenue growth: 16.327826408365137%
Rule of 40 score: 16.327826408365137
Market cap: 33538848768 (Large Cap ($10B-$200B))
P/E ratio: 0.3832657424082881
Debt to equity: 0.0134
Operating income: 5632683.340398474
Net income: 5246926.6638406105
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GRAUWEIL.NS (annual, report date 2026-03-31)
Altman Z-score: 7.203548701330223 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 19.868086907449207%
Earnings yield: 0.06135351610888422%
Return on net tangible assets: 12.726900568472566%
Capitalized R&D asset: 377613.3870352309
ROCI (R&D adjusted): 14.73808073385165%
Rosenberg metric: 0.14456410234964412
Free cash flow margin: 8.249873970761216%
Revenue growth: -4.7974224727307755%
Rule of 40 score: 3.452451498030441
Market cap: 33538848768 (Large Cap ($10B-$200B))
P/E ratio: 0.3832657424082881
Debt to equity: 0.0134
Free cash flow (dilution adjusted): 10405892.327257313
Operating income: 17909071.640525647
Net income: 17382365.40907164
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for HESM (quarterly, report date 2026-03-31)
Altman Z-score: 1.545800303402518 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.200532252699066%
Earnings yield: 2.6933233229273608%
Return on net tangible assets: 36.17760617760617%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.756769825918762%
Free cash flow margin: 57.705171083097504%
Revenue growth: -3.5723145621433887%
Rule of 40 score: 54.132856520954114
Market cap: 8397612544 (Mid Cap ($2B-$10B))
P/E ratio: 13.176470588235293
Debt to equity: 10.064
Free cash flow (dilution adjusted): 224300000
Operating income: 238100000
Net income: 157700000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for IDN (quarterly, report date 2026-03-31)
Altman Z-score: 1.8255500450516648 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.715914034629775%
Earnings yield: 0.8542168335184347%
Return on net tangible assets: 6.925352357751871%
Capitalized R&D asset: 2552940
ROCI (R&D adjusted): 1.998399619584427%
Rosenberg metric: -0.816967792615868
Free cash flow margin: 3.837798696596669%
Revenue growth: -16.74453654860588%
Rule of 40 score: -12.90673785200921
Market cap: 73511928 (Micro Cap ($50M-$300M))
P/E ratio: 58.25000000000001
Debt to equity: 0
Free cash flow (dilution adjusted): 212000
Operating income: 542000
Net income: 636000
Long score: 5 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for JAGSNPHARM.NS (annual, report date 2026-03-31)
Altman Z-score: 23.491446062183744 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 39.814640456521566%
Earnings yield: 0.03540962318164349%
Return on net tangible assets: 26.42524166044437%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.863225130817433%
Free cash flow margin: 15.269910349029505%
Revenue growth: -3.1030681659517785%
Rule of 40 score: 12.166842183077726
Market cap: 14610630656 (Large Cap ($10B-$200B))
P/E ratio: 0.3072237907372436
Debt to equity: 0.0296
Free cash flow (dilution adjusted): 4648050.021195422
Operating income: 5153666.807969479
Net income: 4565705.80754557
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for JAGSNPHARM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 22.37254888935465 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 7.237536945006181%
Earnings yield: 0.006436789408302046%
Return on net tangible assets: 5.590529332230138%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.0654104494432675%
Revenue growth: -16.265759382319295%
Rule of 40 score: -16.265759382319295
Market cap: 14610630656 (Large Cap ($10B-$200B))
P/E ratio: 0.3072237907372436
Debt to equity: 0.0296
Operating income: 936837.6430690971
Net income: 928582.0262823231
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for JYOTICNC.NS (annual, report date 2026-03-31)
Altman Z-score: 8.226680265167364 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 21.064845511205412%
Earnings yield: 0.026852063641156353%
Return on net tangible assets: 3.231666016707376%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.55518168202056%
Free cash flow margin: -12.8434449843058%
Revenue growth: 4.3891373795658275%
Rule of 40 score: -8.454307604739972
Market cap: 180812742656 (Large Cap ($10B-$200B))
P/E ratio: 0.5149464665405713
Debt to equity: 0.4261
Free cash flow (dilution adjusted): -28489826.19754133
Operating income: 50503391.26748622
Net income: 35608308.60534125
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for JYOTICNC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 7.499990585387096 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 5.885161119214959%
Earnings yield: 0.007502011862729109%
Return on net tangible assets: 5.37858418341167%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.463386610312071%
Revenue growth: -1.0219196508390178%
Rule of 40 score: -1.0219196508390178
Market cap: 180812742656 (Large Cap ($10B-$200B))
P/E ratio: 0.5149464665405713
Debt to equity: 0.4261
Operating income: 14109792.284866469
Net income: 9598346.757100467
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for LU2.DE (quarterly, report date 2026-03-31)
Altman Z-score: 8.04582363002256 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 11.539725307222186%
Earnings yield: 0.3566093426435915%
Return on net tangible assets: 8.133661442818289%
Capitalized R&D asset: 171129000
ROCI (R&D adjusted): 5.464351381491018%
Rosenberg metric: 1.4594257178526842
Free cash flow margin: 4.638792676892627%
Revenue growth: 21.472577009767093%
Rule of 40 score: 26.11136968665972
Market cap: 53277437952 (Large Cap ($10B-$200B))
P/E ratio: 132.82758620689654
Debt to equity: 1.1145
Free cash flow (dilution adjusted): 37500000
Operating income: 175600000
Net income: 144200000
Long score: 9 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for MATR.TO (quarterly, report date 2026-03-31)
Altman Z-score: 1.085324912547938 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.8270009036973005%
Earnings yield: 0.8889578274512293%
Return on net tangible assets: 12.174118900363982%
Capitalized R&D asset: 4067944.0214251955
ROCI (R&D adjusted): 1.4554870051685713%
Rosenberg metric: 2.9608067992763125
Free cash flow margin: -10.991097369606761%
Revenue growth: 1.5094564388429486%
Rule of 40 score: -9.481640930763813
Market cap: 1093322112 (Small Cap ($300M-$2B))
P/E ratio: 50.35971223021583
Debt to equity: 0.7474
Free cash flow (dilution adjusted): -25446762.589928057
Operating income: 14493525.179856116
Net income: 5320863.309352518
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for PHAR.L (annual, report date 2025-12-31)
Altman Z-score: 0.6567407530673601 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0.7336757153338225%
Earnings yield: 19.459114488277812%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.3261824760920136%
Free cash flow margin: 26.439790575916234%
Revenue growth: -8.903020667726555%
Rule of 40 score: 17.53676990818968
Market cap: 102701104 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): 40945945.94594595
Operating income: 12162162.162162162
Net income: -8918918.918918919
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PLXS (quarterly, report date 2026-03-31)
Altman Z-score: 3.7896217759232607 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.045002178284402%
Earnings yield: 0.9130316667689752%
Return on net tangible assets: 3.799906027654719%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.750677053100979%
Free cash flow margin: 0.6948185918537977%
Revenue growth: 8.777382292130126%
Rule of 40 score: 9.472200883983923
Market cap: 6808171008 (Mid Cap ($2B-$10B))
P/E ratio: 29.697947214076244
Debt to equity: 0.1797
Free cash flow (dilution adjusted): 8086000
Operating income: 61837000
Net income: 49809000
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for STEELCAS.NS (annual, report date 2026-03-31)
Altman Z-score: 31.683266373420395 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 26.603807321966055%
Earnings yield: 0.03588453295342825%
Return on net tangible assets: 17.271993890600015%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.89400345636915%
Free cash flow margin: 12.915874669913164%
Revenue growth: 2.6000057149709574%
Rule of 40 score: 15.51588038488412
Market cap: 31032979456 (Large Cap ($10B-$200B))
P/E ratio: 0.2774392558123082
Debt to equity: 0
Free cash flow (dilution adjusted): 5712664.2645188635
Operating income: 10785216.193302248
Net income: 9205033.912674863
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for STEELCAS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 30.476922307656412 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 6.780762938761938%
Earnings yield: 0.00914622889049723%
Return on net tangible assets: 6.686258205201699%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.344969123836104%
Revenue growth: 9.81400214836585%
Rule of 40 score: 9.81400214836585
Market cap: 31032979456 (Large Cap ($10B-$200B))
P/E ratio: 0.2774392558123082
Debt to equity: 0
Operating income: 2748929.6311996607
Net income: 2456146.672318779
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SUZLON.NS (annual, report date 2026-03-31)
Altman Z-score: 6.285533224986603 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 40.05413075467732%
Earnings yield: 0.040944203668804%
Return on net tangible assets: 34.03245357709628%
Capitalized R&D asset: 834825.661080276
ROCI (R&D adjusted): 25.61192383161125%
Rosenberg metric: 247.25829217985117
Free cash flow margin: 3.187460242183186%
Revenue growth: 39.33865555182332%
Rule of 40 score: 42.52611579400651
Market cap: 718534082560 (Mega Cap (>= $200B))
P/E ratio: 0.18068728767188358
Debt to equity: 0.0587
Free cash flow (dilution adjusted): 56341670.19923697
Operating income: 290773632.8952946
Net income: 335246926.6638406
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SUZLON.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.368553873822833 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 13.107730128699227%
Earnings yield: 0.013399006841822629%
Return on net tangible assets: 14.14008561373099%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.405674993797948%
Revenue growth: 23.033420091772008%
Rule of 40 score: 23.033420091772008
Market cap: 718534082560 (Mega Cap (>= $200B))
P/E ratio: 0.18068728767188358
Debt to equity: 0.0587
Operating income: 95155786.35014836
Net income: 118095591.3522679
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TATAELXSI.NS (annual, report date 2026-03-31)
Altman Z-score: 20.709161567018988 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 31.597320725044227%
Earnings yield: 0.04016618190341887%
Return on net tangible assets: 23.445964258059764%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.30146345331708%
Free cash flow margin: 17.02570301028335%
Revenue growth: -8.657377661490353%
Rule of 40 score: 8.368325348792998
Market cap: 268058034176 (Mega Cap (>= $200B))
P/E ratio: 0.4092634634252955
Debt to equity: 0.053399999999999996
Free cash flow (dilution adjusted): 67796502.75540483
Operating income: 82555648.57990675
Net income: 66599226.36710471
Long score: 11 | Short score: 1
Recommendation: Long
Stock screener scorecard for TSLA (quarterly, report date 2026-06-30)
Altman Z-score: 13.010505172323771 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0.41572223905073274%
Earnings yield: 0.03290496744815583%
Return on net tangible assets: -3.502268069722996%
Capitalized R&D asset: 4263210000
ROCI (R&D adjusted): 0.6268343674396271%
Rosenberg metric: 0.01593011305241521
Free cash flow margin: -7.9685507862303435%
Revenue growth: 26.126770000446687%
Rule of 40 score: 18.158219214216345
Market cap: 1236326809600 (Mega Cap (>= $200B))
P/E ratio: 382.3636363636364
Debt to equity: 0.1837
Free cash flow (dilution adjusted): -2250000000
Operating income: 398000000
Net income: 1128000000
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 3355.T (annual, report date 2025-12-31)
Altman Z-score: 2.6145568769252687 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 7.59595896985986%
Earnings yield: 0.06293494820499808%
Return on net tangible assets: 3.5651469021858118%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.046884283178149%
Free cash flow margin: 0.1856322390233405%
Revenue growth: 14.27449398692276%
Rule of 40 score: 14.4601262259461
Market cap: 32148773704.512638 (Large Cap ($10B-$200B))
P/E ratio: 8.149718628663779
Debt to equity: 0.407257173205308
Free cash flow (dilution adjusted): 1052547.7910619525
Operating income: 26231602.83869318
Net income: 25220708.394603927
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 367A.T (annual, report date 2025-08-31)
Altman Z-score: 1.4542155659184388 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 43.629021027712014%
Earnings yield: 0.0549026181842172%
Return on net tangible assets: -21.088676349037666%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.716821545823827%
Revenue growth: 11.002215278444648%
Rule of 40 score: 11.002215278444648
Market cap: 16881898518.57 (Large Cap ($10B-$200B))
P/E ratio: 9.452350794272116
Debt to equity: 1.001107910480833
Operating income: 21343415.764016625
Net income: 12167041.351590708
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 9793.T (annual, report date 2026-02-28)
Altman Z-score: 7.5432926214355325 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 19.541030138306844%
Earnings yield: 0.05427616530283344%
Return on net tangible assets: 10.50643991496811%
Capitalized R&D asset: 2552037.6279426496
ROCI (R&D adjusted): 16.25759853241634%
Rosenberg metric: 4.065890340743494
Free cash flow margin: 6.868953998190549%
Revenue growth: 2.7403905675726827%
Rule of 40 score: 9.609344565763232
Market cap: 187014247419.99997 (Large Cap ($10B-$200B))
P/E ratio: 18.90369427069645
Debt to equity: 0.08494898265050418
Free cash flow (dilution adjusted): 31663030.92518927
Operating income: 93641729.75747465
Net income: 63473630.1809316
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CNR.TO (annual, report date 2025-12-31)
Altman Z-score: 2.4105124754241123 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 13.619916051526996%
Earnings yield: 3.607710856017352%
Return on net tangible assets: 14.052838673412033%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.007145591425292%
Free cash flow margin: 19.59662505779011%
Revenue growth: 5.9594005400586205%
Rule of 40 score: 25.55602559784873
Market cap: 81159432999.99998 (Large Cap ($10B-$200B))
P/E ratio: 17.194795127118642
Debt to equity: 1.002874629080119
Free cash flow (dilution adjusted): 2475182481.751825
Operating income: 4808029197.080292
Net income: 3445255474.4525547
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for COGN3.SA (annual, report date 2025-12-31)
Altman Z-score: 0.9126070514655683 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 24.48403808482934%
Earnings yield: 2.4628611696631366%
Return on net tangible assets: -113.25929512069115%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.211760884597049%
Free cash flow margin: 10.672922441907213%
Revenue growth: 23.821874892409276%
Rule of 40 score: 34.49479733431649
Market cap: 6182325126.136877 (Mid Cap ($2B-$10B))
P/E ratio: 9.883512932679706
Debt to equity: 0.4942361619502408
Free cash flow (dilution adjusted): 136657481.7518248
Operating income: 241357481.7518248
Net income: 114145802.91970801
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for FMV.DE (annual, report date 2025-12-31)
Altman Z-score: 5.128583358415809 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.773413021660312%
Earnings yield: 3.745661161819732%
Return on net tangible assets: 14.801747914255861%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.26131976761755%
Free cash flow margin: 23.531071637749307%
Revenue growth: 134.29607948576697%
Rule of 40 score: 157.82715112351627
Market cap: 11651102907.602827 (Large Cap ($10B-$200B))
P/E ratio: 55.22504044366785
Debt to equity: 0.09730328027467043
Free cash flow (dilution adjusted): 217302919.70802918
Operating income: 255424087.59124085
Net income: 153996350.3649635
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for HESM (annual, report date 2025-12-31)
Altman Z-score: 1.7636142453874186 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 30.1736007183478%
Earnings yield: 11.403356748605932%
Return on net tangible assets: 113.16206229104347%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.999523866206403%
Free cash flow margin: 44.92950779124413%
Revenue growth: 8.398686239024062%
Rule of 40 score: 53.32819403026819
Market cap: 4245847143.48 (Mid Cap ($2B-$10B))
P/E ratio: 6.20193856774759
Debt to equity: 8.61383877597625
Free cash flow (dilution adjusted): 726600000
Operating income: 1008100000
Net income: 684600000
Long score: 10 | Short score: 4
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for IDN (annual, report date 2025-12-31)
Altman Z-score: 15.400574185788383 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 10.326138632689931%
Earnings yield: 1.7115857586734686%
Return on net tangible assets: 18.292451036318692%
Capitalized R&D asset: 9442590
ROCI (R&D adjusted): 5.915807082976245%
Rosenberg metric: 0.605133523463832
Free cash flow margin: 15.437218741727698%
Revenue growth: 13.347002050307546%
Rule of 40 score: 28.784220792035242
Market cap: 135278156.28 (Micro Cap ($50M-$300M))
P/E ratio: 106.2672083896308
Debt to equity: 0
Free cash flow (dilution adjusted): 3499000
Operating income: 1086000
Net income: 1273000
Long score: 10 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for MATR.TO (annual, report date 2025-12-31)
Altman Z-score: 1.3651094237518886 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 10.651791955287944%
Earnings yield: 3.25428253936944%
Return on net tangible assets: 43.22481432349536%
Capitalized R&D asset: 15668758.690214895
ROCI (R&D adjusted): 5.454122490631541%
Rosenberg metric: 8.16503327857469
Free cash flow margin: 3.268393285674192%
Revenue growth: 49.55147617585185%
Rule of 40 score: 52.81986946152605
Market cap: 489877085.88 (Small Cap ($300M-$2B))
P/E ratio: 10.523675314285716
Debt to equity: 0.7529072312651728
Free cash flow (dilution adjusted): 30261313.868613135
Operating income: 53057664.23357664
Net income: 33978102.18978102
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for PLXS (annual, report date 2025-09-30)
Altman Z-score: 4.111364100807069 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 13.81257817581428%
Earnings yield: 3.0571803084105538%
Return on net tangible assets: 10.684331233311426%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.79353347416967%
Free cash flow margin: 3.0671966984100534%
Revenue growth: 1.8213115594293818%
Rule of 40 score: 4.888508257839435
Market cap: 3871386554.49 (Mid Cap ($2B-$10B))
P/E ratio: 22.39284237782341
Debt to equity: 0.11494801277062645
Free cash flow (dilution adjusted): 123699000
Operating income: 207054000
Net income: 172885000
Long score: 10 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for VHM.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 74786856 (Micro Cap ($50M-$300M))
Debt to equity: 0.0069
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for WTM.AX (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -51.211521525863105%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -51.25509349777394%
Rule of 40 score: 0
Market cap: 180304832 (Micro Cap ($50M-$300M))
Debt to equity: 0.0012
Free cash flow (dilution adjusted): -8445304.697986577
Operating income: -11720685.234899329
Net income: -11467022.147651007
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for WTM.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 180304832 (Micro Cap ($50M-$300M))
Debt to equity: 0.0012
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3271.T (annual, report date 2025-06-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 29409855036 (Large Cap ($10B-$200B))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3550.T (annual, report date 2026-02-28)
Altman Z-score: 6.296734786416931 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.491354046476498%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.959900852006266%
Free cash flow margin: 6.6988797636219815%
Revenue growth: 7.447314839490842%
Rule of 40 score: 14.146194603112823
Market cap: 3116745899.9999995 (Mid Cap ($2B-$10B))
P/E ratio: 20.566742772678385
Debt to equity: 0
Free cash flow (dilution adjusted): 1773476.1965866801
Operating income: 1535332.9911459
Net income: 972302.0659566276
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 4019.T (annual, report date 2025-12-31)
Altman Z-score: 7.267022232245698 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.301400485347841%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.01559763616692%
Free cash flow margin: -1.4665190779230848%
Revenue growth: 42.316463068855896%
Rule of 40 score: 40.849943990932815
Market cap: 7227984556.118454 (Mid Cap ($2B-$10B))
P/E ratio: 34.7253842530445
Debt to equity: 0.05856675036257745
Free cash flow (dilution adjusted): -357963.0458410588
Operating income: 1861946.1671248642
Net income: 1330778.0832427593
Long score: 9 | Short score: 2
Recommendation: Neutral